Current role
Laural Stoppel, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Laural Stoppel, Ph.D.
Artiva Biotherapeutics, Inc. reported in an 8-K filed January 29, 2025 that Laural Stoppel, Ph.D. was appointed member of the Clinical Strategy Committee, effective January 28, 2025.
“Laura Bessen, M.D., Brian Daniels, M.D., and Laural Stoppel, Ph.D. were also appointed as members, and Diego Miralles, M.D. was appointed as chair, of the Clinical Strategy Committee”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-01-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Artiva Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Fred Aslan CEO, Board Member
- Fred Aslan, M.D. CFO
- Neha Krishnamohan CFO
- Thad Huston CFO
- Jennifer Bush COO
- Alison Moore, Ph.D. Board Member
- Brian Daniels, M.D. Board Member
- Daniel Baker Board Member
- Daniel Baker, Ph.D. Board Member
- Elaine Sorg Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.